WHO Expert Committee on Biological Standardization. Seventy-sixth report

Overview

The seventy-sixth meeting of the WHO Expert Committee on Biological Standardization was held virtually from 24 to 28 October 2022. The meeting was opened on behalf of the Director-General of WHO and the Assistant DirectorGeneral, Access to Medicines and Health Products, by Dr Clive Ondari, Director, Health Products Policy and Standards. Dr Ondari began by welcoming the Committee members, meeting participants and observers. He noted that the now 22-member Committee was well balanced with regard to its expertise, and gender and geographical representativeness. Dr Ondari went on to inform meeting participants of the untimely death of Committee member Dr Patricia Aprea, Director of Evaluation and Control of Biologicals and Radiopharmaceuticals at the National Administration of Drugs, Food and Medical Devices in Argentina. Highlighting Dr Aprea’s expert contributions, including as a drafting group member for the recently published WHO Guidelines on evaluation of biosimilars, Dr Ondari observed that her passing represented a significant loss to the Committee